{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "AUD", "marketState": "PRE", "regularMarketChangePercent": 7.1428614, "regularMarketPrice": 0.075, "exchange": "ASX", "shortName": "NEUROSCIEN FPO", "longName": "NeuroScientific Biopharmaceuticals Limited", "messageBoardId": "finmb_539666516", "exchangeTimezoneName": "Australia/Sydney", "exchangeTimezoneShortName": "AEST", "gmtOffSetMilliseconds": 36000000, "market": "au_market", "esgPopulated": false, "regularMarketTime": 1683782996, "earningsTimestamp": 1682633469, "earningsTimestampStart": 1682633469, "earningsTimestampEnd": 1682633469, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -0.05, "sharesOutstanding": 143472000, "bookValue": 0.019, "fiftyDayAverage": 0.08158, "fiftyDayAverageChange": -0.006579995, "fiftyDayAverageChangePercent": -0.08065697, "twoHundredDayAverage": 0.117465, "twoHundredDayAverageChange": -0.042464994, "twoHundredDayAverageChangePercent": -0.3615119, "marketCap": 11375250, "priceToBook": 3.9473686, "sourceInterval": 20, "exchangeDataDelayedBy": 20, "tradeable": false, "cryptoTradeable": false, "firstTradeDateMilliseconds": 1532649600000, "priceHint": 4, "regularMarketChange": 0.0050000027, "regularMarketDayHigh": 0.075, "regularMarketDayRange": "0.071 - 0.075", "regularMarketDayLow": 0.071, "regularMarketVolume": 29018, "regularMarketPreviousClose": 0.07, "bid": 0.071, "ask": 0.075, "bidSize": 0, "askSize": 0, "fullExchangeName": "ASX", "financialCurrency": "AUD", "regularMarketOpen": 0.071, "averageDailyVolume3Month": 45956, "averageDailyVolume10Day": 71463, "fiftyTwoWeekLowChange": 0.0065000057, "fiftyTwoWeekLowChangePercent": 0.0948906, "fiftyTwoWeekRange": "0.0685 - 0.28", "fiftyTwoWeekHighChange": -0.205, "fiftyTwoWeekHighChangePercent": -0.73214287, "fiftyTwoWeekLow": 0.0685, "fiftyTwoWeekHigh": 0.28, "symbol": "NSB.AX"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "85 Forrest Street", "address2": "Suite 5", "city": "Cottesloe", "state": "WA", "zip": "6011", "country": "Australia", "phone": "61 8 6382 1805", "website": "https://www.neuroscientific.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "NeuroScientific Biopharmaceuticals Limited develops therapeutic treatments for neurodegenerative diseases through preclinical and clinical studies of patented technologies. Its lead drug candidates include EmtinB for treatment of neurodegenerative dementia and Alzheimer's disease, and degenerative conditions of the optic nerve. The company was incorporated in 2002 and is based in Cottesloe, Australia.", "companyOfficers": [{"maxAge": 1, "name": "Mr. Paul John Rennie BSc, Grad Dip, MBM, MSTC", "age": 63, "title": "Interim CEO & CHairman", "yearBorn": 1959, "fiscalYear": 2022, "totalPay": {"raw": 176678, "fmt": "176.68k", "longFmt": "176,678"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Abby  Macnish Niven B.Com., B.Sc., C.F.A.", "title": "CFO & Company Sec.", "fiscalYear": 2022, "totalPay": {"raw": 65002, "fmt": "65k", "longFmt": "65,002"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dougal  Thring", "title": "Chief Operating Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}